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ABSTRACT Amyloid ﬁbril formation is a distinctive hallmark of a number of degenerative diseases. In this process, protein
monomers self-assemble to form insoluble structures that are generally referred to as amyloid ﬁbrils. We have induced
in vitro amyloid ﬁbril formation of a PDZ domain by combining mechanical agitation and high ionic strength under conditions
otherwise close to physiological (pH 7.0, 37C, no added denaturants). The resulting aggregates enhance the ﬂuorescence
of the thioﬂavin T dye via a sigmoidal kinetic proﬁle. Both infrared spectroscopy and circular dichroism spectroscopy detect
the formation of a largely intermolecular b-sheet structure. Atomic force microscopy shows straight, rod-like ﬁbrils that are similar
in appearance and height to mature amyloid-like ﬁbrils. Under these conditions, before aggregation, the protein domain adopts
an essentially native-like structure and an even higher conformational stability (DGU-F
H2O). These results show a new method for
converting initially folded proteins into amyloid-like aggregates. The methodological approach used here does not require dena-
turing conditions; rather, it couples agitation with a high ionic strength. Such an approach offers new opportunities to investigate
protein aggregation under conditions in which a globular protein is initially folded, and to elucidate the physical forces that
promote amyloid ﬁbril formation.INTRODUCTION
Peptides and proteins have a generic tendency to convert
from their soluble states into well organized aggregates char-
acterized by a fibrillar morphology and an extended cross-
b structure (1,2). The formation of such fibrillar aggregates
(generally termed ‘‘amyloid fibrils’’ when they deposit
in vivo in the extracellular space) is associated with a number
of human diseases, including neurodegenerative conditions,
localized amyloidoses, and systemic amyloidoses (3,4). It is
becoming apparent, however, that the formation of amyloid-
like fibrils is not necessarily deleterious and associated with
pathology. Indeed, evidence is mounting that a number of
organisms exploit formation of these fibrillar species to carry
out specific biological functions (4,5). In addition, amyloid-
like fibrils formed in vitro can have a wide range of novel
properties that are useful in research, medicine, and industry
(6,7).
More than 40 proteins that have no link to protein deposi-
tion diseases have been converted into amyloid-like fibrils
in vitro under appropriate experimental conditions (1,2).
Our ability to reproduce the process of amyloid fibril forma-
tion in vitro with nondisease proteins has increased our
potential to investigate the fundamentals of this process. It
has also created an awareness that amyloid fibrils—and
more generally self-assembled polypeptide chains—can in
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of new biological nanomaterials, because proteins are very
diverse in terms of sequence (6,7). The in vitro formation
of amyloid-like fibrils by normally folded proteins generally
requires harsh conditions, such as pH extremes (8,9), high
temperature values (10,11), high pressure values (12,13),
or the presence of organic cosolvents (14,15). Such harsh
denaturing conditions are highly favorable for promoting
aggregation because they unfold, at least partially, folded
proteins and generate ensembles of highly fluctuating
conformations that have a high propensity to aggregate (4).
In a recent very interesting report (16), amyloid formation
by initially folded hen lysozyme and human b2-microglobu-
lin was obtained by a two-step procedure that consisted of 1),
agitating the protein samples at high ionic strength; and 2),
heating. The first step allowed the two proteins to form
native-like aggregates, whereas the second denaturing step
enabled the conversion of the native-like assemblies into
amyloid-like fibrils. In a more recent report (17), the same
authors showed that amyloid fibril formation by b2-micro-
globulin can also be achieved in the absence of a heating
step by simply incubating the protein at neutral pH and
37C, initially under agitation at high ionic strength and
then for 25–45 days under the same conditions in the absence
of agitation. Here we report the formation of amyloid-like
fibrils by a novel globular protein, the second PDZ domain
of murine Protein Tyrosine Phosphatase-Bas-Like (PDZ2),
under conditions that are conceptually distinct from the
denaturing procedures previously utilized. The conversion
doi: 10.1016/j.bpj.2008.11.042
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at high ionic strength, at neutral pH, 37C, and atmosphere
pressure, and in the absence of organic cosolvents. Unlike
generally used procedures, neither heating nor any other
denaturing condition was used in this case. In addition to
showing evidence of fibril formation by a novel protein
and presenting a novel methodology to form amyloid from
a normally folded protein, this approach has implications
for the study of the amyloidogenesis process. It may facilitate
investigation of new driving forces of aggregation and allow
the process to be studied under conditions in which the
protein is initially folded.
PDZ domains are a large family of proteins that mediate
protein-protein interactions (18). These globular protein
domains generally consist of 80–100 residues that fold into
six b-strands and two a-helices (Fig. 1). The folding mech-
anism of this fold family has been extensively investigated,
and analysis of the folding kinetics of different members
led to the depiction of a consensus folding mechanism
(19). In the case of PDZ2, the presence of an intermediate
was evidenced from complex folding kinetics observed
under certain experimental conditions (20), and its kinetic
role was recently clarified (21). Moreover, extensive f-value
analysis, together with constrained molecular-dynamics
simulations, contributed to the structural description of the
early and late transition states that characterize PDZ folding
(22). A critical review of the PDZ domain family recently
highlighted an intriguing correlation between folding and
binding parameters (23). Hence, this fold family represents
an ideal candidate to explore the role of structural plasticity
in tuning the physiological function of proteins.
Despite the large quantity of data collected on the folding
mechanism of PDZ2 and other PDZ domains, the process of
amyloid fibril formation by PDZ domains has not been
investigated in any detail. In this work we will show that
incubation of PDZ2 using a novel protocol converts this
protein domain from its soluble folded state into fibrillar
aggregates that are tinctorially, morphologically, and struc-
turally indistinguishable from both the natural fibrils associ-
ated with human pathology and the synthetic fibrils formed
in vitro under the ‘‘traditional’’ conditions that make use of
chemical or physical denaturants.
MATERIALS AND METHODS
Protein puriﬁcation
To express PDZ2, a modified pET28a vector was used that contained
a construct constituted by a poli-histidine tag (MH6) fused to the 94-residue
sequence coding for the domain (24). Escherichia coli BL21(DE3) cells
containing the engineered vector were grown under vigorous shaking in
LB medium at 37C up to 0.7 OD600. Protein expression was induced by
incubation with 1 mM IPTG (isopropyl b-D-1-thiogalactopyranoside) over-
night at 25C. Cells were harvested by centrifugation at 2800 g and by re-
suspending the pellet in 50 mM sodium phosphate, pH 7.0. The resulting
cell suspension was sonicated (six to seven cycles of 30 s sonication at
25 kHz and 100 W alternated with 30 s in ice) and centrifuged atBiophysical Journal 96(6) 2289–229831,000 g. The supernatant was passed through a column packed with
His-Select Affinity Gel (Sigma-Aldrich, St. Louis, MO) at room tempera-
ture. Bound protein was abundantly washed with 20 mM sodium phosphate,
pH 7.0, and then eluted with 700 mM imidazole. The solution containing the
eluted protein was subjected to cycles of alternating ultrafiltration (cutoff
10,000) and dilution steps, using 20 mM sodium phosphate, pH 7.0, to elim-
inate imidazole. By contrast, the protein domain used to acquire Fourier
transform-infrared (FTIR) spectra in native conditions was exchanged
against 20 mM ammonium carbonate by the same procedure and lyophilized
with an Alpha 2-4 LSC freeze dryer (Christ, Osterode, Germany). Protein
purity was checked by means of sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE). Protein concentration was determined
by UV absorption using 3280 ¼ 5500 M1 cm1.
Protein aggregation
A fresh solution containing PDZ2 at a concentration of 0.4 mg mL1,
20 mM sodium phosphate, 1 M NaCl, pH 7.0, was prepared and poured
into a Hellma ‘‘reduced-volume’’ quartz cell (product number 119.004F;
Hellma, Mu¨llheim, Germany). The outer dimensions of the cell were
49.5 mm (height), 12.5 mm (width), and 12.5 mm (depth); the pathlength
was 10  4 mm and the total volume was 1.5 mL. The volume of the added
sample was 1.5 mL, a volume equal to the cuvette capacity. The resulting
cell containing the sample was preequilibrated at 37C for 10 min in
a J-810 spectropolarimeter (Jasco, Tokyo, Japan) with a thermostated cell
holder attached to a Thermo C25P water bath (Haake, Karlsruhe, Germany).
The protein sample was agitated for 24 h at 750 rpm using the Electronic
Stirrer (model 300; Rank Brothers Ltd., Cambridge, UK) and the analytical
magnetic stir bar provided with the cell (length and diameter approximately
6 and 3 mm, respectively). No cleavage of the PDZ2 polypeptide chain
FIGURE 1 Three-dimensional structure of the second PDZ domain from
murine Protein Tyrosine Phosphatase Bas-like (PDZ2). The structure was
depicted using the software PyMOL v. 0.99 (DeLano Scientific LLC, South
San Francisco, CA) and refers to the NMR structure, PDB entry 1GM1 (24).
Amyloid Formation by PDZ2 2291occurred on this timescale, as checked with electro-spray ionization mass
spectrometry. Agitation at 450 rpm, using the same apparatus and protein
sample, is not effective at inducing PDZ2 fibril formation.
Thioﬂavin-T ﬂuorescence
PDZ2 was incubated under the following conditions: 1), at a PDZ2 concen-
tration of 0.4 mg mL1 in 20 mM sodium phosphate buffer, 1 M NaCl, pH
7.0, 37C, under stirring at 750 rpm; 2), under the same conditions in the
absence of stirring; 3), under the same conditions in the absence of NaCl;
and 4), under the same conditions in the absence of both stirring and
NaCl. From each sample 62 mL aliquots were withdrawn at regular times
and added to 438 mL of a solution containing 25 mM Thioflavin-T (ThT),
25 mM sodium phosphate buffer, pH 6.0. The resulting sample was excited
at 440 nm and the fluorescence emission at 485 nm was measured at 25C
using a 2 10-mm-pathlength quartz cuvette (Hellma, Mu¨llheim, Germany)
and an LS 55 spectrofluorimeter (Perkin-Elmer, Wellesley, MA) equipped
with a thermostated cell holder attached to an F8 water bath (Haake). The
ratio between ThT emission in the presence (F) and absence (F0) of PDZ2
was reported. ThT fluorescence emission spectra between 450 and 550 nm
were obtained after 0 and 24 h incubation under condition 1 using the
same procedure and instrumentation described above.
Far-UV circular dichroism
PDZ2 was incubated at a concentration of 0.4 mg mL1 in 20 mM sodium
phosphate buffer, 1 M NaCl, pH 7.0, 37C, under stirring at 750 rpm. Far-
UV circular dichroism (CD) spectra were recorded at 37C before agitation
and after 24 h agitation, using a 1-mm-pathlength quartz cuvette (Hellma,
Mu¨llheim, Germany) and a J-810 spectropolarimeter (Jasco, Tokyo, Japan)
equipped with a thermostated cell holder attached to a Thermo C25P water
bath (Haake). To analyze the aggregation kinetics, 130 mL aliquots were
withdrawn at regular times and the CD signal was measured at 222 nm.
FTIR spectroscopy
In a first experiment, PDZ2 was incubated at a concentration of 0.4 mg mL1
in 20 mM sodium phosphate buffer, 1 M NaCl, pH 7.0, 37C, under stirring
at 750 rpm, for 24 h. The protein sample underwent cycles of alternating
centrifugation at 16,000 g for 10 min and resuspension of the pellet in
D2O (first time) and 20 mM deuterated sodium phosphate buffer, 1 M
NaCl, pH 7.0 (second and third times). The fourth time, the pellet was resus-
pended in 20 mM deuterated sodium phosphate buffer, 1 M NaCl, pH 7.0,
to achieve a final volume of 20 mL and a final protein concentration of
~15 mg mL1. In a second experiment, PDZ2 dissolved in a solution con-
taining 20 mM ammonium carbonate was lyophilized and resuspended in
D2O to achieve a final volume of 20 mL and a final protein concentration
of ~35 mg mL1. In both cases the obtained 20 mL sample was deposited
on a CaF2 window in a semipermanent liquid cell. The pathlengths used
for the first and second samples were 6 and 12 mm, respectively. The
FTIR spectra between 400 and 4000 cm1 were recorded at room tempera-
ture using an FT/IR 4100 spectrophotometer (Jasco). The background
spectra were subtracted from the sample spectra. For both samples 64 scans
were accumulated at a spectral resolution of 4 cm1, and the Amide I region
(1600–1700 cm1) was isolated and baseline corrected. The system was
purged with N2 for 15 min before spectra were recorded, and then purged
constantly during recording to remove water vapor.
Tapping-mode atomic force microscopy
PDZ2 was incubated at a concentration of 0.4 mg mL1 in 20 mM sodium
phosphate buffer, 1 M NaCl, pH 7.0, 37C, under stirring at 750 rpm for
24 h. To avoid salt crystallization during atomic force microscopy (AFM)
measurements, NaCl was removed by centrifuging the protein sample at
16,000 g for 10 min, resuspending the pellet in 20 mM sodium phosphate,
pH 7.0, and diluting 100-fold by adding water. After dilution, 20 mL aliquotsof this suspension were immediately deposited on a freshly cleaved mica
substrate and dried under a gentle nitrogen flux. Tapping-mode (TM)
AFM images were acquired in air using a Dimension 3100 microscope
(Digital Instruments, Santa Barbara, CA) equipped with a ‘‘G’’ scanning
head (maximum scan size 100 mm) and driven by a Nanoscope IIIa
controller. Single-beam uncoated silicon cantilevers (type AC160TS,
Olympus, Santa Barbara, CA) were used. The drive frequency was
~300 kHz and the scan rate was 0.3–1.0 Hz. Fibril sizes were measured
from the height in cross section of the topographic AFM images. Because
of the drying procedure applied to achieve sample adhesion to the mica
substrate, the measured heights are underestimated with respect to fully
hydrated conditions and should be corrected by multiplying them by a factor
that, as a first approximation, can be assumed to be equal to that estimated
previously (1.4) for a different amyloidogenic protein (25). The values re-
ported in the Results section (see Fig. 5) are raw data without correction.
Near-UV CD
PDZ2 was diluted to a final concentration of 0.2 mg mL1 in 20 mM sodium
phosphate buffer, pH 7.0, 25C, with and without 1 M NaCl. Near-UV CD
spectra were acquired at 25C, shortly after diluting the stocked protein
sample into these solutions. An identical sample containing 1 M NaCl
was incubated at 37C under stirring at 750 rpm for 3 h before its near-
UV CD spectrum was acquired at 25C. A 10-mm-pathlength quartz cuvette
(Hellma, Mu¨llheim, Germany) and the CD instrument described above (see
‘‘Far-UV circular dichroism’’) were used. Each spectrum was recorded as
the average of 15 scans.
Intrinsic ﬂuorescence
PDZ2 was diluted to a final concentration of 0.4 mg mL1 in 20 mM sodium
phosphate buffer, pH 7.0, 25C, with and without 1 M NaCl. Fluorescence
spectra were acquired at 25C, shortly after diluting the stocked protein
sample into these solutions. An identical sample containing 1 M NaCl
was incubated at 37C under stirring at 750 rpm for 3 h before its fluores-
cence spectrum was acquired at 25C. Fluorescence spectra were acquired
using the cuvette and instrumental apparatus described above (see ‘‘Thiofla-
vin-T fluorescence’’). The excitation wavelength was set at 280 nm and the
emission range was 300–450 nm. Each spectrum was recorded as the
average of three scans.
8-Anilino-1-naphthalenesulfonic acid
ﬂuorescence
PDZ2 was diluted to a final concentration of 0.02 mg mL1 in 55 mM 8-ani-
lino-1-naphthalenesulfonic acid (ANS), 20 mM sodium phosphate buffer,
pH 7.0, at 25C, with and without 1 M NaCl. Spectra were acquired at
25C, shortly after diluting the stocked protein sample into these solutions.
A sample containing 0.2 mg mL1 PDZ, 20 mM sodium phosphate buffer,
1 M NaCl, no ANS, was incubated for 3 h at 37C under stirring at 750 rpm.
It was then diluted 10-fold in a sample containing ANS. The final conditions
were 55 mM ANS, 20 mM sodium phosphate buffer, 1 M NaCl, pH 7.0,
25C. Fluorescence spectra were acquired using the same cell and equip-
ment described under ‘‘Thioflavin-T fluorescence’’. The excitation wave-
length was set at 380 nm and the emission range was 410–630 nm. Spectra
were also acquired for the corresponding solutions in the absence of protein.
Each spectrum was recorded as the average of three scans. ANS concentra-
tion was determined spectrophotometrically using an 3375 value of
8000 mL mmol1 cm1.
Equilibrium unfolding
Urea-induced unfolding of PDZ2 at equilibrium was measured by moni-
toring the decrease in intrinsic fluorescence of the protein at various wave-
lengths on increasing urea concentration. The final conditions were
0.015 mg mL1 PDZ2, 20 mM phosphate, pH 7.0, 25C, and ureaBiophysical Journal 96(6) 2289–2298
2292 Sicorello et al.concentrations ranging from 0 to 8 M in the presence or absence of 1 M
NaCl. In each of the two studied conditions (with and without 1 M NaCl)
the plots of intrinsic fluorescence versus urea concentration obtained at
100 different wavelengths were fitted globally to the equation previously
described by Santoro and Bolen (26). The resulting DGU-F
H2O, m, and Cm
values were obtained from such a global fitting in both conditions.
RESULTS
Aggregation of PDZ2 in the presence of salt
and stirring
To induce aggregation of PDZ2, the protein domain was
incubated at a concentration of 0.4 mg mL1 in 20 mM
sodium phosphate buffer, pH 7.0, 37C, in the presence of
1 M NaCl, under stirring at 750 rpm. At regular time inter-
vals, aliquots of this sample were withdrawn to carry out
ThT fluorescence assays. Fig. 2 A shows the ThT spectrum
obtained in the presence of the protein domain incubated
under these conditions for 24 h. A 21-fold enhancement of
ThT fluorescence emission was observed with respect to
the blank. In contrast, a sample of PDZ2 that was not prein-
cubated under these conditions did not bind ThT, as demon-
strated by the absence of a fluorescence emission increase
(Fig. 2 A). The time course of ThT fluorescence reveals
a lag-phase of ~16 h, followed by a rapid increase and a satu-
ration of the signal after ~26 h (Fig. 2 B). We repeated the
experiment by incubating the protein domain under the
same conditions in the absence of stirring, under the same
conditions in the absence of NaCl, and under the same condi-
tions in the absence of both stirring and agitation. In all three
cases the time courses of ThT fluorescence were not charac-
terized by an increase of ThT fluorescence on the investi-
gated timescale, indicating that both agitation and a high
ionic strength are necessary factors to promote the observed
increase of ThT fluorescence on this timescale (Fig. 2 B).
Aggregates of PDZ2 have extensive b-sheet
structure
The far-UV CD spectrum of PDZ2, incubated in the absence
of agitation in 20 mM sodium phosphate, 1 M NaCl, pH 7.0,
37C, reveals a negative peak at ~215–219 nm and shoulders
at 209 and 222 nm (Fig. 3 A). This structure is consistent
with an a/b protein in which the b-sheet structure is preva-
lent. In contrast, the spectrum acquired after incubating
PDZ2 for 24 h in the same condition under agitation at
750 rpm and in the presence of 1 M NaCl shows only a single
broad negative peak around 225 nm (Fig. 3 A). Even though
this peak is red-shifted with respect to the canonical b-sheet
profile, such a feature is typical of amyloid material orga-
nized in large aggregates (16,27,28). The red shift of the
peak wavelength and the decrease of signal intensity could
be explained by the so-called differential absorption flat-
tening effect arising from heterogeneous samples in which
a solid-state material is suspended in solution (29). The
time course of the change in mean residue ellipticity atBiophysical Journal 96(6) 2289–2298222 nm reveals a lag phase and a rapid-growth phase
substantially superimposable on those detected with ThT
fluorescence (Fig. 3 B). Again, the absence of a plateau in
the late aggregation phase could be attributed to the rapidly
increasing influence of the differential absorption flattening
effect. The remarkable parallelism between ThT fluores-
cence and far-UV CD time courses suggests that very mild
structural changes occur during the first 12 h, and that aggre-
gates with ordered b-sheet structure form rapidly later on.
FIGURE 2 (A) ThT fluorescence spectra in the presence of PDZ2 preincu-
bated at a concentration of 0.4 mg mL1, in 20 mM sodium phosphate, 1 M
NaCl, pH 7.0, 37C, under agitation at 750 rpm for 24 h (solid line). ThT
fluorescence spectra in the presence of PDZ2 preincubated for a few minutes
in the same conditions but in the absence of agitation (dotted line) and in the
presence of the incubation solution without PDZ2 (dashed line) are also re-
ported. (B) Time course of ThT fluorescence emission at 480 nm for PDZ2
preincubated under the same conditions described for panel A (solid circles),
under the same conditions in the absence of stirring (solid triangles), under
the same conditions in the absence of NaCl (open circles) and under the
same conditions in the absence of both stirring and NaCl (open squares).
The ratio between the ThT fluorescence emission in the presence (F) and
absence (F0) of PDZ2 is reported on the y axis of the figure.
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incubated under the same conditions, we used FTIR spec-
troscopy. We first analyzed the native protein domain. In
this case a protein sample dissolved in 20 mM ammonium
carbonate was lyophilized and then resuspended in deuter-
ated water (D2O). The Amide I region of the resulting
FTIR spectrum shows a maximum absorption at
1638 cm1 and a large band typical of an a/b fold with
high content in the intramolecular b-sheet, in agreement
with the above-mentioned far-UV CD spectrum (Fig. 4 A).
We then incubated the protein domain under agitation at
750 rpm for 24 h in 20 mM sodium phosphate, 1M NaCl,
FIGURE 3 (A) Far-UV CD spectra of PDZ2 incubated at a concentration
of 0.4 mg mL1, in 20 mM sodium phosphate, 1 M NaCl, pH 7.0, 37C with
(solid line) and without (dotted line) agitation at 750 rpm for 24 h. (B)
Change of the mean residue ellipticity at 222 nm as a function of incubation
time under agitation in the conditions described for panel A.37C. After incubation, the protein sample was centrifuged
and resuspended in 20 mM deuterated sodium phosphate,
1 M NaCl (see Materials and Methods for further details).
The Amide I region of the FTIR spectrum recorded for the
resulting sample features a maximum absorbance at
1621 cm1 (Fig. 4 B). This peak is in the range of 1615–
1630 cm1, and is known to arise from intermolecular
b-sheet structure typical of amyloid fibrils (30,31).
Aggregates of PDZ2 have a ﬁbrillar morphology
To assess the nature of the protein species formed after a 24 h
incubation under the conditions used here, a morphological
analysis was performed by means of TM-AFM. The analysis
revealed the presence of aggregates constituted by rather
thick rod-like fibrillar structures with a typical length of
a few hundreds of nanometers (Fig. 5, A and B). These
straight formations show, perpendicularly to their
FIGURE 4 FTIR Amide I spectra of PDZ2 obtained in native conditions
(A) and after incubation under stirring at high ionic strength (B). (A) PDZ2
domain was lyophilized and dissolved in D2O. (B) PDZ2 was incubated at
a concentration of 0.4 mg mL1 in 20 mM sodium phosphate, 1 M NaCl,
pH 7.0, 37C, under stirring at 750 rpm for 24 h. The resulting solution
was centrifuged and the aggregates of the pellet were resuspended in
20 mM deuterated sodium phosphate buffer, 1 M NaCl, pH 7.0 (see Mate-
rials and Methods for further details).Biophysical Journal 96(6) 2289–2298
2294 Sicorello et al.FIGURE 5 (A and B) TM-AFM
image of aggregates formed by PDZ2.
Aggregates were produced by incu-
bating the protein domain at a concentra-
tion of 0.4 mg mL1, in 20 mM sodium
phosphate, 1 M NaCl, pH 7.0, 37C,
under agitation at 750 rpm for 24 h.
(A) Height data (scan size 870 nm, Z
range 30 nm); (inset) distribution of
fibril height measured from cross
sections of TM-AFM topographic
images. (B) Amplitude data (scan size
870 nm; not quantitative in height),
revealing the fibril ultrastructure in
more detail. (C and D) Typical cross-
section profiles of PDZ2 fibrils. Red,
green, and black arrows facilitate the
association between the topographic
measurements (left) and the correspond-
ing features in the TM-AFM images
(right).longitudinal axis, a mild streaking on their surface (Fig. 5, A
and B); such features are commonly associated with amyloid
fibrils with tightly wound protofilaments (32). The statistical
analysis of fibril height, measured from the height in cross
section of topographic AFM images, yielded a bimodal
distribution with a main peak at 4.9  0.1 nm and a smaller
one at 10.2  0.4 nm (Fig. 5 A, inset). The highest fibrillar
species seem to arise from a partial or complete superimpo-
sition of distinct fibrils with a lower height. Typical cross-
section profiles are reported in Fig. 5, C and D. However,
since the sample was dried to allow its adhesion to the
mica substrate before performing the AFM analysis, the re-
ported height measurements underestimate the real fibrillar
diameter in solution. To obtain more realistic diameter
values, a correction should be applied by multiplying the
measured heights by a factor of 1.4 (25). After this correc-
tion, the heights of the thinnest fibrils observed are still
consistent with amyloid fibrils, typically 7–13 nm. Protofila-
ments and protofibrils should have lower diameters, typically
2–5 nm.
Hence, the morphological analysis performed here using
TM-AFM allows the direct observation of aggregate species
with characteristics reminiscent of amyloid-like fibrils. The
analysis allows the presence of amorphous, protofilament,
and protofibrillar species to be excluded after 24 h of incuba-
tion under these conditions. Amorphous aggregates would
have a nonfibrillar appearance. Protofibrils would have
a lower height than that observed here for the thinnest fibrils,
and a spherical, curvilinear, or annular appearance. Protofila-
ments would appear straight, but again with a much lower
height than that of the thinnest species actually observed. It
is still possible that all of these species, or some of them,
form transiently during the process as intermediate aggre-Biophysical Journal 96(6) 2289–2298gates, but the analysis shows that after 24 h amyloid-like
fibrils predominate in the sample.
PDZ2 adopts a native-like structure under
conditions promoting aggregation
To explore the conformational state adopted by PDZ2 under
the conditions used here to promote amyloid fibril formation,
but before the initiation of aggregation, we compared the
spectroscopic properties of PDZ2 in 1), 20 mM sodium
phosphate buffer, pH 7.0, in the absence of salts and agita-
tion; and 2), 20 mM sodium phosphate buffer, 1 M NaCl,
pH 7.0, before and after starting agitation. In the first condi-
tion the protein is stable in its native state and does not
undergo aggregation. In the second condition PDZ2
undergoes amyloid fibril formation, but the time courses
acquired using ThT fluorescence and far-UV CD show that
within the first 3 h no fibrils accumulate in the sample
(Figs. 2 B and 3 B). The comparison of the spectroscopic
properties of PDZ2 under the two conditions therefore
allowed us to probe possible conformational changes of
PDZ2 after incubation in the presence of salt and agitation,
before aggregation was effectively initiated.
We first acquired near-UV CD spectra in the absence of
salt and agitation, in the presence of 1 MNaCl before starting
agitation and in the presence of 1 M NaCl after 3 h agitation
(Fig. 6 A). Unfortunately, the protein has no detectable CD
signal in the near-UV region, even at high protein concentra-
tions (Fig. 6 A). We therefore acquired intrinsic fluorescence
spectra of the protein in the same conditions, that is, in the
absence of salt and agitation, in the presence of 1 M NaCl
before agitation, and in the presence of NaCl after 3 h
agitation (Fig. 6 B). The spectra are very similar, within
Amyloid Formation by PDZ2 2295FIGURE 6 (A) Near-UV CD spectra
of 0.2 mg mL1 PDZ2 in 20 mM
sodium phosphate, pH 7.0, 25C (solid
line), 20 mM sodium phosphate, 1 M
NaCl, pH 7.0, 25C, before starting
agitation (dashed line), and in 20 mM
sodium phosphate, 1 M NaCl, pH 7.0,
25C, after 3 h agitation at 37C (dotted
line). (B) Intrinsic fluorescence spectra
of 0.4 mg mL1 PDZ2 in 20 mM
sodium phosphate, pH 7.0, 25C (solid
line), 20 mM sodium phosphate, 1 M
NaCl, pH 7.0, 25C, before starting
aggregation (dashed line), and in
20 mM sodium phosphate, 1 M NaCl,
pH 7.0, 25C, after 3 h agitation at
37C (dotted line). The inset shows
the intrinsic fluorescence at 354 nm
versus NaCl concentration before agita-
tion (solid triangles), as well as the cor-
responding signals after 0 h (open
square) and 3 h (solid circle) under
agitation in 1 M NaCl at 37C. (C)
Fluorescence spectra of 55 mM ANS
in the presence of 0.02 mg mL1
PDZ2, in 20 mM sodium phosphate,
pH 7.0, 25C (solid line), 20 mM
sodium phosphate, 1 M NaCl, pH 7.0,
25C (dashed line), and in 20 mM
sodium phosphate, 1 M NaCl, pH 7.0, after 3 h agitation at 37C (dotted line). The spectrum of 55 mMANS in the absence of protein is also shown as a control
(line with solid circles). (D) Urea-induced unfolding curves at equilibrium for 0.015 mg mL1 PDZ2 in 20 mM sodium phosphate, pH 7.0, 25C in the absence
(open circles) and presence (solid circles) of 1 MNaCl. The reported curves were acquired using intrinsic fluorescence at 322 nm and normalized to the fractionof folded protein.experimental error, indicating that the chemical environment
around tryptophan and tyrosine residues is not significantly
different under aggregating and nonaggregating conditions.
We also acquired fluorescence spectra of ANS in the pres-
ence of PDZ2 under the different conditions (Fig. 6 C).
PDZ2 does not change the intrinsic fluorescence of ANS in
either of the conditions tested. The spectra of ANS acquired
in the absence or presence of PDZ2, under any of the three
tested conditions, are superimposable (Fig. 6 C). This indi-
cates that PDZ2 has no significantly exposed hydrophobic
clusters in its native state, and that the situation is maintained
in the presence of salts and agitation. Overall, the spectro-
scopic analysis reported here indicates that monomeric
PDZ2 adopts an essentially native-like tertiary structure
under conditions promoting aggregation.
To assess whether the native state of PDZ2 is thermody-
namically destabilized or stabilized under conditions
promoting aggregation, relative to nonaggregating condi-
tions, we acquired equilibrium urea-induced unfolding
curves of PDZ2 in the presence and absence of salt (Fig. 6
D). The urea-induced transitions of PDZ2 appear to be
highly cooperative in both conditions, suggesting that urea-
induced unfolding occurs via an apparent two-state mecha-
nism. However, it is clear that unfolding occurs at higher
concentrations of urea in the presence of salt (Fig. 6 D).
The analysis of the two curves with a two-state model (26)yields values of 2.57  0.02 and 3.5  0.1 M for the
midpoint of unfolding (Cm) in the absence and presence of
salt, respectively. The same analysis yields values of 3.1 
0.1 and 3.85  0.3 kcal mol1 for the free energy change
of unfolding (DGU-F
H2O) in the absence and presence of salt,
respectively, further confirming that the native protein is
stabilized in the presence of NaCl. By contrast, the coopera-
tivity of the unfolding process is similar in the two condi-
tions, with m values of 1.2  0.03 and 1.1  0.1 kcal M1
mol1, respectively.
DISCUSSION
Formation of amyloid-like ﬁbrils by PDZ2 in the
presence of nondestabilizing conditions
Incubation of PDZ2 under the conditions explored here
allows the conversion of this a/b protein domain from its
native, folded state into fibrillar aggregates that appear to
be structurally, morphologically, and tinctorially indistin-
guishable from the amyloid fibrils associated with protein
deposition diseases. The morphological inspection carried
out using TM-AFM indicates that the aggregates consist
of short and straight fibrils, have a characteristic periodic
texture, and have a height typical of amyloid-like fibrils
(Fig. 5). The aggregates bind ThT, causing a 21-fold
enhancement of its intrinsic fluorescence (Fig. 2 A), andBiophysical Journal 96(6) 2289–2298
2296 Sicorello et al.are characterized by an extensive b-sheet structure, as indi-
cated by far-UV CD and FTIR spectroscopy (Figs. 3 A and
4 B). The FTIR analysis, in particular, shows that the
b-sheet structure is intermolecular in nature and typical of
amyloid-like fibrils (Fig. 4 B). The time course of PDZ2
aggregation exhibits the characteristic kinetic profile gener-
ally observed for fibril formation, with a lag-phase followed
by a rapid growth (Figs. 2 B and 3 B). Hence, using the
three criteria commonly used to classify protein aggregates
as amyloid fibrils (fibrillar morphology, cross-b structure,
and binding to specific diagnostic dyes), the aggregates of
PDZ2 formed here have characteristics reminiscent of
amyloid-like fibrils.
As shown by a number of studies published in the last
decade, harsh denaturing conditions are usually required to
induce amyloid fibril formation of initially folded proteins.
These include pH extremes (8,9), high temperature (10,11),
high pressure (12,13), and cosolvents such as 2,2,2-trifluor-
oethanol (14,15). Amyloid fibril formation at physiological
or nearly physiological conditions generally requires seeding
the reaction with fibrillar aggregates that have been pre-
formed under extreme conditions (33–35). The data pre-
sented here on PDZ2 indicate that agitation and a high ionic
strength in the absence of denaturing agents may be suffi-
cient to promote amyloid fibril formation by a normally
folded protein. Neither heating nor a low pH, nor any other
chemical or physical denaturant, is required to induce
amyloid fibril formation by this initially folded protein.
Indeed, under the conditions used here, before aggregation
has initiated to any significant extent, PDZ2 retains an essen-
tially native-like structure (Fig. 6, A–C) and the conforma-
tional stability of the native fold appears to be even higher
relative to a similar buffer devoid of NaCl in which aggrega-
tion does not occur (Fig. 6 D).
Amyloidogenic effect of salts and agitation
In a recent elegant study (16), it was shown that stirring and
a high ionic strength may be used to trigger native-like
aggregation of human b2-microglobulin and hen lysozyme
in conditions of physiological pH, temperature, and pressure.
The resulting aggregates are native-like and may be con-
verted into amyloid-like fibrils by a further heating step
(16). In a more recent report (17), the same authors showed
that amyloid fibril formation by b2-microglobulin can also be
accomplished in the absence of a heating step by simply
incubating the protein at neutral pH and 37C, initially under
agitation at high ionic strength and then for 25–45 days
under the same conditions in the absence of agitation. The
findings reported previously for b2-microglobulin and those
described here for PDZ2 show that amyloid fibril formation
in the absence of persistent denaturing agents may be an
important and widespread phenomenon.
As shown here for PDZ2 and previously for other systems
(36,37), a high ionic strength increases the thermodynamicBiophysical Journal 96(6) 2289–2298stability of the folded state of a protein, i.e., it increases the
DGU-F
H2O value. Nor is agitation thought to be an unfolding-
inducing agent per se for globular proteins. The aggrega-
tion-promoting effects of salts and agitation presumably
have a different rationale. High salt concentrations are
known to induce aggregation of intrinsically unfolded or
pH-unfolded proteins (25,38–40). Salts exert this aggrega-
tion triggering effect by several possible mechanisms. They
attenuate repulsive electrostatic interactions between protein
molecules in solution via a generic Debye-Huckel screening
effect (41). Ions can also bind to oppositely charged amino
acid residues on the protein and partially neutralize the over-
all net charge of the protein molecule; this results again in
a weakening of the electrostatic repulsion between protein
monomers (40). Salts also act indirectly by perturbing the
hydration shell of the protein molecule and inducing protein
surface desolvation (39,42). Either effect can predominate
depending on the conditions and the protein. A combination
of both direct protein-salt interactions and changes of water
structure has also been proposed (43).
Mechanical forces, such as agitation, shaking, or simple
shear flow, have also been reported to accelerate fibril
formation from intrinsically disordered proteins (44–46) or
globular proteins partially unfolded under nonphysiological
conditions (16,47). Only the recent report on b2-microglo-
bulin described amyloid fibril formation of an initially
folded protein in the absence of destabilizing agents (17).
Regardless of the structural and dynamical nature of the
amyloidogenic nuclei, it is reasonable to think that stirring
can persistently spread nuclei and growing fibrils over the
entire suspension, enhancing the efficiency of seeding. Stir-
ring can also act as a controlled simple shear flow, as re-
ported in a recent study (47). Subsequent to that study, it
was proposed that shear flow favors the orientation and
deformation of a protein so that aggregates that are able
to act as seeds can form more efficiently (47). Agitation
can cause transient and local structural fluctuations in
a sample of folded protein molecules and create a radial
gradient of protein concentration, with areas characterized
by high local concentrations. Moreover, similarly to sonica-
tion, stirring can cause the fracturing of fibrils to generate
new growing ends (44,48). As recently shown for prion
propagation, the naturally occurring fragmentation of fibrils
could be important to amplify the number of fibrillar ends
available for further elongation in a chain-reaction mecha-
nism (49,50). The small length of the PDZ2 fibrils observed
here in the late growth phase is consistent with mechanisms
of this type and could result from the agitation-induced
breakage of growing fibrils or fresh generation of nuclei
that act as seeds. In summary, all of the factors mentioned
here, including the generation of areas with high protein
concentrations, the transient and local deformation of
protein molecules, and the fracturing and resuspension
of growing fibrils, contribute to the profibrillogenic effect
of agitation.
Amyloid Formation by PDZ2 2297CONCLUSIONS
The nature of the chemical and physical agents used here to
induce amyloid formation by initially native PDZ2, and the
investigation into why amyloid fibril formation by initially
folded proteins can occur under these relatively unexplored
conditions will allow new aspects of the fundamentals of
this process to be determined. Furthermore, the use of phys-
iological values of temperature, pressure, and pH, and the
absence of chemical denaturants, such as alcohol cosolvents,
will allow the process of aggregation to be investigated under
conditions in which the protein is initially native and free to
access locally unfolded states by those structural fluctuations
that normally occur physiologically. Protocols of this type
therefore open new avenues into the exploration of processes
of amyloid fibril formation that may shed new light on those
that occur physiologically.
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